Eli Lilly Appoints Thomas Fuchs as First Chief AI Officer, $LLY, Effective October 21, 2024

Oct 11, 2024, 08:48 AM

Eli Lilly has appointed Thomas Fuchs as its first Chief AI Officer, effective October 21, 2024. Fuchs, who is the founder of Paige AI and serves as Dean and Department Chair for AI and Human Health at Mount Sinai, will lead the company's efforts in leveraging artificial intelligence to enhance drug discovery and development processes. This strategic move aims to drive innovation and improve patient outcomes. Diogo Rau, Eli Lilly's Executive Vice President and Chief Financial Officer, emphasized the company's commitment to utilizing advanced technologies in its operations. The appointment comes amid broader discussions about the regulation of AI in healthcare.